Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series

Pembrolizumab-induced adrenal insufficiency (AI) is recognized as a rare immune-related adverse event (irAE) that can be fatal if diagnosis is delayed. Clinical features of AI in patients with advanced non-small cell lung cancer (NSCLC) who received pembrolizumab as the first-line treatment were obs...

Full description

Bibliographic Details
Main Authors: Kei Sonehara, Kazunari Tateishi, Taisuke Araki, Masamichi Komatsu, Jumpei Akahane, Hiroshi Yamamoto, Masayuki Hanaoka
Format: Article
Language:English
Published: Karger Publishers 2021-11-01
Series:Case Reports in Oncology
Subjects:
non-small cell lung cancer
pembrolizumab
adrenal insufficiency
immune-related adverse events
Online Access:https://www.karger.com/Article/FullText/519597

Internet

https://www.karger.com/Article/FullText/519597

Similar Items